No travel, no tourists… no problem? Bloustein School Distinguished Research Professor Michael Lahr visits this troubled $1T industry, reveals who has been hardest hit, and shares how some companies might be able to weather the current storm on the Rutgers-New Brunswick video series, “What Happens Next? Rutgers Experts On Life after the COVID-19 Recovery.”
Lindenfeld & Mauri Find Uptick for MOUD at FQHCs
Introduction To reduce morbidity and mortality among individuals with opioid use disorder (OUD), the evidence is strongest for medications for OUD (MOUD), which include methadone, buprenorphine, and naltrexone. Federally qualified health centers (FQHCs) are essential...
